Michele Carrer
Ionis Pharmaceuticals (United States)
ORCID: 0000-0002-6464-9584Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Use of antisense oligonucleotides to target Notch3 in skeletal cells”.
Michele Carrer, Tabitha Eller, Lauren Schilling, Jungeun Yu, Ernesto Canalis
Magda Mocarska, Lauren Schilling, Paymaan Jafar‐Nejad, Michele Carrer, Ernesto Canalis
Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah‐Reum Oh +10 more
Xian Zhou, Michele Carrer, Paymaan Jafar‐Nejad, Yanfeng Li, Naomi M. Gades +5 more
Michele Carrer, Alyaa Shmara, Cheng Cheng, Hong Yin, Lac Ta +13 more
Xian Zhou, Michele Carrer, Paymaan Jafar‐Nejad, Yanfeng Li, Naomi M. Gades +5 more
Jungeun Yu, Lauren Schilling, Paymaan Jafar‐Nejad, Michele Carrer, Ernesto Canalis
Michele Carrer, Alyaa Shmara, Ángela M Martin, Hong Yin, Pallabi Pal +14 more
Ah‐Reum Oh, Young Hoon Jung, Kyung Hee Jung, Seongju Lee, Michele Carrer +5 more